Letter to the editor: Successful treatment with vincristine by slow infusion in a patient with refractory anemia and excess of blasts
K. Itoh,T. Igarashi,H. Wakita
DOI: https://doi.org/10.1002/ajh.2830390119
1992-01-01
Abstract:Myelodysplastic syndrome (MDS) is characterized by progressive refractory cytopenias with hematopoietic dysfunction that frequently progress to acute myeloid leukemia. Although treatment with cytotoxic or differentiation-inducing agents (low-dose cytosine arabinoside, vitamin D3), has been partly successful, neither specific nor generally effective therapies for MDS exist at this time [I] . We report a case of refractory anemia with excess of blasts (RAEB) who showed an excellent clinical and hematologic remission following vincristine by slow infusion. A 75-year-old man entered our hospital in November 1989 because of persistent fever of 1 month’s duration, pancytopenia, and deterioration of his general condition. He had had a pulmonary tuberculosis at 22 years of age. There was a history of cerebral thrombosis and mild speech disturbance. On physical examination, the palpebra1 conjunctiva were pale. There were moist rales over the entire chest and petechiae on the legs. Peripheral blood showed a hemoglobin of 8.7 g/dl, white blood cell (WBC) count 2.0 X 109/L (neutrophils 67%, lymphocytes 19%, monocytes 13%, and basophils l%), platelets 10 X 109/L. There were a few myeloblasts in the blood film. Bone marrow aspirate was hypocellular with dyshematopoiesis and had 7.4% myeloblasts, 48.0% myeloid series, and 21.3% erythroid series. Auer rods were absent. Bone marrow biopsy showed a hypocellular marrow (25% cellularity). Bone marrow chromosomal analysis of the patient showed 46, X, -Y, 11, 8q+, 19p+, +2mar, in 4 of 10 banded metapheses. The remaining six metapheses were 46,XY. Laboratory findings were as follows: lactic dehydrogenase 1167 IU/L, uric acid 4.3 mg/dl, total bililubin 2.1 mg/dl, direct bililubin 1 .O mg/dl, haptoglobin 10 mg/dl, plateletassociated IgG 13 1.6 ngi lo7 cells, and serum lysozyme 5.7 pg/ml. Coombs test was negative. A diagnosis of RAEB with hypocellular bone marrow was made. The patient was treated conservatively with replacement therapy, but he was refractory to platelet transfusion. In view of the patient’s poor condition, vincristine (0.02 mg/kg over 6 hr) was given on the 6th and the 15th hospital days. After treatment the platelet count increased to 127 X 109/L, and his condition improved, this was maintained for 3 months. After vincristine by slow infusion, bone marrow aspirate had 5% myeloblasts; chromosomal analysis of 20 metaphases showed a normal karyotype of 46,XY in December 1989. A percentage of